RaQualia Pharma Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for RaQualia Pharma.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 12.6% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 14 Feb 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 3,826 | 875 | N/A | N/A | 1 |
12/31/2023 | 1,901 | -323 | -940 | -718 | N/A |
9/30/2023 | 2,509 | 139 | -88 | 123 | N/A |
6/30/2023 | 2,485 | 279 | 2 | 156 | N/A |
3/31/2023 | 2,949 | 695 | 834 | 898 | N/A |
12/31/2022 | 2,918 | 723 | 1,449 | 1,480 | N/A |
9/30/2022 | 3,057 | 1,053 | 721 | 757 | N/A |
6/30/2022 | 2,903 | 922 | 565 | 607 | N/A |
3/31/2022 | 2,460 | 447 | 639 | 686 | N/A |
12/31/2021 | 2,776 | 755 | 261 | 366 | N/A |
9/30/2021 | 2,157 | 261 | 204 | 367 | N/A |
6/30/2021 | 2,055 | 155 | -65 | 114 | N/A |
3/31/2021 | 1,639 | -90 | -577 | -371 | N/A |
12/31/2020 | 1,107 | -606 | -444 | -289 | N/A |
9/30/2020 | 1,567 | -162 | -178 | -81 | N/A |
6/30/2020 | 1,529 | -144 | -239 | -174 | N/A |
3/31/2020 | 1,478 | -221 | -34 | -11 | N/A |
12/31/2019 | 1,702 | 5 | -624 | -530 | N/A |
9/30/2019 | 920 | -791 | -857 | -707 | N/A |
6/30/2019 | 844 | -818 | -922 | -774 | N/A |
3/31/2019 | 695 | -895 | -948 | -720 | N/A |
12/31/2018 | 744 | -1,104 | -624 | -403 | N/A |
9/30/2018 | 1,345 | -439 | -317 | -155 | N/A |
6/30/2018 | 1,401 | -367 | -260 | -67 | N/A |
3/31/2018 | 1,398 | -304 | -115 | 1 | N/A |
12/31/2017 | 1,419 | -58 | -395 | -307 | N/A |
9/30/2015 | 93 | -2,154 | N/A | -2,281 | N/A |
6/30/2015 | 103 | -2,021 | N/A | -2,233 | N/A |
3/31/2015 | 143 | -2,033 | N/A | -2,209 | N/A |
12/31/2014 | 153 | -638 | N/A | -2,081 | N/A |
9/30/2014 | 230 | 338 | N/A | -2,095 | N/A |
6/30/2014 | 241 | 256 | N/A | -2,100 | N/A |
3/31/2014 | 221 | 432 | N/A | -2,170 | N/A |
12/31/2013 | 228 | -1,108 | N/A | -2,179 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4579's forecast earnings growth is above the savings rate (0.2%).
Earnings vs Market: Insufficient data to determine if 4579's earnings are forecast to grow faster than the JP market
High Growth Earnings: Insufficient data to determine if 4579's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 4579's revenue is forecast to grow faster than the JP market.
High Growth Revenue: Insufficient data to determine if 4579's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4579's Return on Equity is forecast to be high in 3 years time